Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
Guardado en:
Autores principales: | Nouran Fakhry, Ahmed Gowily, Tarek Okda, Maha Houssen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96f2d13ce5ee4157b8bd2c819b1e6a1d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum soluble Toll-like receptor 4 and the risk of hepatocellular
carcinoma in hepatitis C virus patients
por: Maha Elkammah, et al.
Publicado: (2021) -
EXPRESSION FEATURES OF TOLL-LIKE RECEPTOR 2 AND TOLL-LIKE RECEPTOR 4 IN CHILDREN WITH ASTHMA
por: L. V. Gankovskaya, et al.
Publicado: (2017) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
por: Amani E. Khalifa, PhD, et al.
Publicado: (2021) -
Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
por: Wang Z, et al.
Publicado: (2020) -
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Anastazja M. Gorecki, et al.
Publicado: (2021)